X0508 4 2025-06-03 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0002025621 Shields Matthew C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 124 DVORA HANEVI'A ST., TEL AVIV L3 6944020 ISRAEL false true false false EVP, Global Operations false Ordinary Shares 2025-06-03 4 M false 16195 A 16195 D Ordinary Shares 2025-06-03 4 S false 6206 17.0203 D 9989 D Restricted Share Units 2025-06-03 4 M false 16195 0 D Ordinary Shares 16195 48587 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II. Restricted share units were granted on June 3, 2024 with 16,195 vested on June 3, 2025, 16,195 vesting on each of June 3, 2026 and June 3, 2027, and 16,197 vesting on June 3, 2028. /s/ Dov Bergwerk as attorney-in-fact for Matthew Shields 2025-06-05